BPC-157 is a 15-amino-acid pentadecapeptide derived from a gastric protective sequence, with a molecular weight of approximately 1,419 Da, and is most often investigated in connective-tissue, tendon, and gastrointestinal models where angiogenic and nitric-oxide-pathway effects dominate the literature [5]
Our 10ml bacteriostatic water is pharmaceutical-grade and sized to pair conveniently with standard peptide vials
In the pivotal STRATUM trial, nearly 80% of individuals achieved the primary efficacy endpoint of Investigators Global Assessment (IGA) Success, with just over 50% reaching complete clearance at week 8
The peptide is not currently known to cause dependence, and researchers have not identified a withdrawal syndrome similar to what can occur with certain prescription medications
It is not approved by the FDA for human consumption, therapeutic use, or veterinary application
Wherever any of these signs occur, dispose of the vial at once